nicardipine has been researched along with Obesity in 2 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is often related to metabolic disorders, such as android obesity, glucose intolerance, dyslipidemia, and hyperinsulinism (X syndrome)." | 6.67 | Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group. ( Boucher, L; Cozic, JA; Gorlier, R; Huin, P; Pettenuzzo-Mollo, M; Provendier, O; Raccah, D; Sicard, J; Vague, P, 1994) |
| "Hypertension is often related to metabolic disorders, such as android obesity, glucose intolerance, dyslipidemia, and hyperinsulinism (X syndrome)." | 2.67 | Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group. ( Boucher, L; Cozic, JA; Gorlier, R; Huin, P; Pettenuzzo-Mollo, M; Provendier, O; Raccah, D; Sicard, J; Vague, P, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raccah, D | 1 |
| Pettenuzzo-Mollo, M | 1 |
| Provendier, O | 1 |
| Boucher, L | 1 |
| Cozic, JA | 1 |
| Gorlier, R | 1 |
| Huin, P | 1 |
| Sicard, J | 1 |
| Vague, P | 1 |
| Pezzarossa, A | 1 |
| Cimicchi, MC | 1 |
| Orlandi, N | 1 |
| Gnudi, A | 1 |
| Manca, C | 1 |
| Perrone, A | 1 |
| Bolognesi, R | 1 |
1 trial available for nicardipine and Obesity
| Article | Year |
|---|---|
Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group.
Topics: Adult; Aged; Antigens; Blood Pressure; Captopril; Double-Blind Method; Factor VII; Female; Fibrinoge | 1994 |
1 other study available for nicardipine and Obesity
| Article | Year |
|---|---|
Lack of effect of nicardipine and diltiazem on glucose- and arginine-induced insulin release in obese subjects.
Topics: Arginine; Diltiazem; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Male; Nicardipine; Ob | 1988 |